Found 95 results in Expert Content

Summary: Discover Catalent's expert team and their vital role in ensuring timely delivery of investigational medicinal products for successful clinical supply projects.

Summary: Learn about the MRCT trends in studies from China to overseas, as well as how clinical supply strategy considerations in different clinical phases can help in understanding risk assessment when developing a global supply plan.

Find out when to consider Case Management Services for your cell or gene therapy project

Summary: This webinar addresses the main steps and process to help proactively mitigate risks and optimize the clinical supply chain.

Summary: This webinar addresses key challenges in the development, manufacturing and supply chain logistics for autologous and allogeneic cell therapies.

In this Executive Summary, learn best practices and the necessary proactive steps that need to be taken to build a solid clinical supply plan.

Summary: This webinar focuses on understanding your knowns and unknowns, best practices for mitigating risk and addressing the specific drug supply challenges commonly associated with adaptive, decentralized, platform and other complex trial designs.

Summary: This webinar focuses on best practices in the pre-award phase to build a functional relationship with your clinical supply partner, solidify a compelling strategy and drive alignment for success.

Summary: Case Management Services provides end-to-end supply chain management and orchestration for autologous and allogeneic cell, gene and gene-modified therapies. Designed specifically to address the unique challenges associated with the safe and timely delivery of advanced therapies to patients.

In this Executive Summary, Catalent reviews which therapeutic areas are ripe for highly decentralized trials and which areas will be least resistant to this kind of change.